New weekly shot aims to tame type 2 diabetes
NCT ID NCT07668388
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new medicine called UBT251, given as a weekly shot, in 300 adults with type 2 diabetes. Some participants will get UBT251, others will get a placebo or an existing drug (semaglutide). The goal is to see if UBT251 can safely lower blood sugar and help with weight loss.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
UBT251 (a weekly injection for type 2 diabetes)
What this could lead to
If successful, UBT251 could offer a new once-weekly option to help control blood sugar and possibly reduce weight in people with type 2 diabetes.
What could go wrong
This is an early Phase 2 dose-finding study, so it is not yet proven effective or safe. Side effects are unknown, and results may not lead to a better treatment than existing options like semaglutide.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS (TYPE 2) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
1 Wojskowy Szpital Kliniczny z Poliklinika SPZOZ
Lublin, Lublin Voivodeship, 20-049, Poland
-
ARETEUS s.r.o.
Trebišov, 075 01, Slovakia
-
Ark Clinical Research
Fountain Valley, California, 92708, United States
-
Ark Clinical Research
Long Beach, California, 90815, United States
-
Asan Medical Center_Endocrinology
Seoul, 05505, South Korea
-
Baker Heart and Diabetes Institute
Melbourne, Victoria, 3004, Australia
-
CRS Clinical Research Mannheim GmbH (hVIVO Mannheim)
Mannheim, 68167, Germany
-
Castle Hill Medical Centre
Castle Hill, New South Wales, 2154, Australia
-
Catalina Research Institute, LLC
Montclair, California, 91763, United States
-
Chosun University Hospital_Endocrinology
Gwangju, 61453, South Korea
-
Chrysalis Clinical Research
St. George, Utah, 84790, United States
-
Clinica Korall S.R.L. Satu Mare
Satu Mare, 440055, Romania
-
Clinical Best Solutions Sp. z o.o., Sp. k
Lublin, 20-011, Poland
-
Consano Clin Res-Shavano Park
Shavano Park, Texas, 78231, United States
-
Cotton O'Neil Diabetes & Endocrinology
Topeka, Kansas, 66606, United States
-
DSP Bochum, Diabetes- und Stoffwechselpraxis
Bochum, 44869, Germany
-
Eap Osona Sud Alt Congost S.L.P
Centelles (Barcelona), 08540, Spain
-
Encore Medical Research LLC
Hollywood, Florida, 33021, United States
-
Encore Medical Research of Weston
Weston, Florida, 33331, United States
-
Equip D'assistencia Primaria Vic S.L.P.
Vic, Barcelona, 08500, Spain
-
Flourish Research
Birmingham, Alabama, 35205, United States
-
Formed 2 Sp. z o.o.
Oświęcim, 32-600, Poland
-
H. Infanta Luisa_Endocrino y Obesidad
Seville, 41010, Spain
-
Herz- und Diabeteszentrum NRW - Bad Oeynhausen
Bad Oeynhausen, 32545, Germany
-
Hospital Universitario Marqués de Valdecilla
Santander, 39008, Spain
-
Hospital Universitario de la Princesa
Madrid, 28006, Spain
-
Hospital Vall d'Hebron
Barcelona, 08035, Spain
-
Hunter Medical Research Institute - Endocrinology and Diabetes
New Lambton Heights, New South Wales, 2305, Australia
-
IMA Clinical Research
Austin, Texas, 78745, United States
-
IN-DIA s.r.o.
Lučenec, 984 01, Slovakia
-
InnoDiab Forschung GmbH
Essen, 45136, Germany
-
KDCILM, LLC & Accellacare US, Inc.
Wilmington, North Carolina, 28401, United States
-
Korea University Guro Hospital_Endocrinology
Seoul, 08308, South Korea
-
LifeDoc Health
Memphis, Tennessee, 38115, United States
-
Los Angeles Institute for Metabolic Research
Los Angeles, California, 90015, United States
-
MD Medical Research
Oxon Hill, Maryland, 20745, United States
-
MEDI-DIA s.r.o.
Sabinov, 08301, Slovakia
-
MEDISPEKTRUM s.r.o.
Bratislava, 851 01, Slovakia
-
Mariodiab Clinic SRL
Brasov, 500101, Romania
-
Medizinisches Versorgungszentrum Am Bahnhof Spandau GbR
Berlin, 13597, Germany
-
Mesut Durmaz, Hof
Hof, 95030, Germany
-
Midwest Inst For Clin Res
Indianapolis, Indiana, 46260, United States
-
Monroe Biomedical Research, LLC
North Charleston, South Carolina, 29406, United States
-
NZOZ Vita-Diabetica Malgorzata Buraczyk
Bialystok, Podlaskie Voivodeship, 15-879, Poland
-
PVN Kutató Kft.
Budapest, 1102, Hungary
-
PharmQuest
Greensboro, North Carolina, 27408, United States
-
Plains Clinical Research Center, LLC_Fargo
Fargo, North Dakota, 58104, United States
-
Preferred Primary Care Physicians, Inc.
Uniontown, Pennsylvania, 15401, United States
-
Private Practice - Dr. Laila A. Hassan
Houston, Texas, 77089, United States
-
Pécsi Tudományegyetem ÁOK
Pécs, 7624, Hungary
-
Quality Research Inc
San Antonio, Texas, 78209, United States
-
Radiance Clinical Research
Lampasas, Texas, 76550, United States
-
Roger Chih Yu Chen
Sydney, New South Wales, 2148, Australia
-
Royal Adelaide Hospital - Cardiology Department
Adelaide, South Australia, 5000, Australia
-
S.C Milena Sante SRL
Galati, 800001, Romania
-
S.C. Top Diabet Srl
Craiova, Dolj, 200515, Romania
-
SC Nutrilife SRL
Bucharest, 013764, Romania
-
Semmelweis Egyetem
Budapest, 1083, Hungary
-
South Broward Research LLC
Miramar, Florida, 33027, United States
-
Specjalistyczna Praktyka Lekarska Diabetologia, Leczenie Cukrzycy i Otyłości lek. Monika Piwowar
Kielce, 25-355, Poland
-
Spitalul Clinic Judetean De Urgenta Pius Brinzeu Timisoara
Timișoara, 300723, Romania
-
Studiengesellschaft Dres. Könemann/Steinmann GbR
Bünde, 32257, Germany
-
Szegedi Tudomanyegyetem St Györgyi Albert Klinikai Központ
Szeged, Csongrád-Csanád, 6725, Hungary
-
Szent Margit Rendelőintézet Nonprofit Kft.
Budapest, 1032, Hungary
-
Tekton Research Inc
San Antonio, Texas, 78258, United States
-
The Catholic University of Korea, Seoul ST. Mary's Hospital_Endocrinology
Seoul, 06591, South Korea
-
The Vancouver Clinic
Vancouver, Washington, 98664, United States
-
Uniwersytecki Szpital Kliniczny w Bialymstoku
Bialystok, 15-276, Poland
-
Versdias - Diabetologikum Amberg
Amberg, Bavaria, 92224, Germany